Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study

Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study

ObjectivesHydroxychloroquine (HCQ) is widely used to treat rheumatic diseases including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and Sjögren’s syndrome (SS). Cardiac arrhythmia has been concerned as important safety issue for HCQ. The aim of this study was to investigate whether...

Full description

Bibliographic Details
Main Authors: Chien-Hsien Lo, James Cheng-Chung Wei, Yu-Hsun Wang, Chin-Feng Tsai, Kuei-Chuan Chan, Li-Ching Li, Tse-Hsien Lo, Chun-Hung Su
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Immunology
Subjects:
Hydroxychloroquine
arrhythmia
rheumatoid arthritis
systemic lupus erythematosus
Sjögren's syndrome
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.631869/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.631869/full

Similar Items